Asthma; Eosinophilic Clinical Trial
Official title:
Predictive Response Factors in Respondent Patients and Results After Monoplane Switch in Patients With Severe Eosinophilic Asthma Treated With Benralizumab
Retrospective, multicenter, routine clinical practice study with consecutive inclusion of adult patients with severe eosinophilic asthma receiving benralizumab treatment.
Retrospective study studying severe eosinophilic asthma. Patients with this disease who are on benralizumab treatment for at least 4 months before the start of the study will be included. The purpose of this study is to analyze the predictive factors of response in patients with this type of disease treated with benralizumab, who obtain a complete response during their follow-up. The results of the study will be obtained through the review of medical records, where demographic characteristics such as age, gender and smoking will be assessed; presence of comorbidities; clinical-functional variables; response variables (exercises, cycles of oral corticosteroids, admissions, visits to the emergency room or unscheduled, cumulative dose of oral corticosteroids, absenteeism from work) and side effects. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04742504 -
Interaction Between Benralizumab and Basophils in Eosinophilic Asthma
|
||
| Recruiting |
NCT04565483 -
Predictive Signature of Benralizumab Response
|
Phase 4 | |
| Completed |
NCT04181190 -
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
|
||
| Recruiting |
NCT05787678 -
Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion
|
||
| Completed |
NCT04456270 -
Asthma Control in a Dutch Primary Care Population
|
||
| Not yet recruiting |
NCT05091385 -
Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma
|
||
| Recruiting |
NCT04512521 -
Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma
|
||
| Recruiting |
NCT05813288 -
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
|
Phase 3 | |
| Recruiting |
NCT04319705 -
Anti-viral Effects of Azithromycin in Patients With Asthma and COPD
|
Phase 4 | |
| Recruiting |
NCT06288516 -
BenRalizumab Effect on Airway Remodeling in Severe asTHma
|
Phase 4 | |
| Active, not recruiting |
NCT03733535 -
Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI
|
N/A | |
| Not yet recruiting |
NCT05241769 -
The Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic Asthma
|
||
| Not yet recruiting |
NCT05404763 -
Mepolizumab and Physical Activity in Severe Asthma
|
||
| Not yet recruiting |
NCT04924478 -
Evaluation of Volatile Organic Compounds in Mepolizumab Therapy
|
||
| Recruiting |
NCT05748600 -
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
|
Phase 3 | |
| Recruiting |
NCT05763121 -
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
|
Phase 3 | |
| Completed |
NCT03453021 -
Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma
|
||
| Active, not recruiting |
NCT04612556 -
Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO)
|
||
| Completed |
NCT04710134 -
Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma
|
Phase 4 | |
| Not yet recruiting |
NCT05144087 -
The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
|